'Pay-for-delay' plan blocked cheap generic challengers to Peninsula company's narcolepsy drug for years, lawsuits claim

Legal maneuvering by the company effectively blocked a generic drug for narcolepsy from entering the market since 2011.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news